Two special types of breast cancer presenting as progressive disease after neoadjuvant chemotherapy with docetaxel plus doxorubicin

Breast Cancer

Volumn 8, Issue 3, 2001, Pages 234-237

  Takahashi, Tsunehiro ^a   Akashi Tanaka, Sadako ^a   Fukutomi, Takashi ^a   Watanabe, Toru ^a   Katsumata, Noriyuki ^a   Miyakawa, Kunihisa ^a   Hasegawa, Tadashi ^b   Tsuda, Hitoshi ^b  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Breast cancer; Inflammatory breast cancer; Neoadjuvant chemotherapy; Progressive disease; Squamous cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; DOCETAXEL; DOXORUBICIN; DRUG DERIVATIVE; PACLITAXEL; TAXOID;

ADJUVANT THERAPY; ADULT; ARTICLE; BONE TUMOR; BREAST TUMOR; CASE REPORT; DISEASE COURSE; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAMMOGRAPHY; METASTASIS; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; RADIOGRAPHY; SQUAMOUS CELL CARCINOMA; STERNUM;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; DOXORUBICIN; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAMMOGRAPHY; MIDDLE AGED; NEOADJUVANT THERAPY; PACLITAXEL; STERNUM; TAXOIDS;

EID: 0035233737     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967514     Document Type: Article

References (14)

1. Costa SD, von Minckwitz G, Raab G, et al: The role of docetaxel (Taxotere) in neoadjuvant chemotherapy of breast cancer. Semin Oncol 26 (3 Suppl 9):24-31, 1999. (Pubitemid 29340754)
2. Akashi-Tanaka S, Fukutomi T, Watanabe T, et al: Accuracy of contrast-enhanced computed tomography in the prediction of residual breast cancer after neoadjuvant chemotherapy. Int J Cancer 96:66-73, 2001. (Pubitemid 32147686)
3. Committee for Production of Histopathological Criteria, Japanese Breast Cancer Society: Histopathological criteria for assessment of therapeutic response in breast cancer. Breast Cancer 8:1-2, 2001.
4. Fisher B, Bryant J, Wolmark N, et al: Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16:2672-2685, 1998. (Pubitemid 28363030)
5. Sobin LH, Wittekind Ch (editors): Breast tumors. In: International Union Against Cancer (UICC), TNM Classification of malignant tumors, 5th ed, Wiley-Liss, New York, pp126-127, 1997.
6. Singletary SE, Ames FC, Buzdar AU: Management of inflammatory breast cancer. World J Surg 18:87-92, 1994. (Pubitemid 24100698)
7. Fleming RY, Asmar L, Buzdar AU, et al: Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma. Ann Surg Oncol 4:452-461, 1997. (Pubitemid 127725217)
8. Kokufu I, Yamamoto M, Fukuda K, et al: Squamous cell carcinoma of the breast: three case reports. Breast Cancer 6:63-68, 1999.
9. Cornog JL, Mobini J, Steiger E, et al: Squamous cell carcinoma of the breast. Am J Clin Pathol 55:410-417, 1971.
10. Toikkanen S: Primary squamous cell carcinoma of the breast. Cancer 48:1629-1632, 1981. (Pubitemid 12199425)
11. Gauden SJ: Primary squamous cell carcinoma of the breast. Australas Radiol 36:253-254, 1992.
12. Misonou J, Aizawa M, Nakamura S, et al: A rare autopsy involving primary squamous cell carcinoma of the breast showing a very rapid and aggressive clinical course. Jpn J Cancer Clin 33:1833-1838, 1987.
13. Okada K, Makihara K, Okada M, et al: A case of primary squamous cell carcinoma of the breast with rapid progression. Breast Cancer 7:160-164, 2000.
14. Dejager D, Redlich PN, Dayer AM, et al: Primary squamous cell carcinoma of the breast: sensitivity to cisplatinum-based chemotherapy. J Surg Oncol 59:199-203, 1995.